A randomised controlled trial to study the effect of pradarari churna and pushyanuga churna in the management of asrugdara

A Randomised Controlled Trial To Evaluate The Efficacy Of Pradarari Churna And Pushyanuga Churna In The Management Of Asrigdara(Dysfunctional Uterine Bleeding) - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082368

Enrollment

Registered

2025-03-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patient heaving heavy menstrual bleeding with change of 7-8 fully soaked pads/day prolonged bleeding for more than 7 days Intermenstrual bleeding within 21 days Hemoglobin more than 8gm/dl Both married and unmarried women

Exclusion criteria

Exclusion criteria: Patient diagnosed with genetic bleeding disorder and other systemic coagulative disorders Medical conditions as Acute PID, Liver disease, Chronic renal disease, HIV, TB, Diabetes mellitus, hypertension and Thyroid disorder Fibroid uterus, Uterine polyps, Adenomyosis, Tumors Pelvic endometriosis Medication as OCP, Warfarin, Enoxaparin, Apixaban and other anticoagulant drugs Patient with IUCD, Chronic illness and Postmenopausal bleeding

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Pradarari churna and Pushyanuga churna in AsrugdaraTimepoint: 4 months	—

Secondary

Measure	Time frame
To compare the efficacy of Pradarari churna and Pushyanuga churna in the management of Arugdara(Dysfunctional uterine bleeding)Timepoint: 4 months	—

Countries

India

Contacts

Public ContactDr Supriya M

Shree Jagadguru Gavisiddheshwar ayurvedic medical college and hospital

drsupriyaprashanth@gmail.com9480010072

Outcome results